Quantinno Capital Management LP Boosts Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Quantinno Capital Management LP grew its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 706.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 190,969 shares of the pharmacy operator's stock after buying an additional 167,292 shares during the quarter. Quantinno Capital Management LP's holdings in Walgreens Boots Alliance were worth $1,782,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Golden State Wealth Management LLC purchased a new position in Walgreens Boots Alliance in the 4th quarter valued at about $26,000. Riverview Trust Co raised its holdings in shares of Walgreens Boots Alliance by 123.8% during the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock valued at $27,000 after acquiring an additional 1,590 shares during the last quarter. Colonial Trust Co SC raised its holdings in shares of Walgreens Boots Alliance by 79.5% during the fourth quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock valued at $27,000 after acquiring an additional 1,297 shares during the last quarter. Venturi Wealth Management LLC purchased a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $28,000. Finally, Independence Bank of Kentucky acquired a new stake in shares of Walgreens Boots Alliance in the fourth quarter worth approximately $39,000. 58.59% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Walgreens Boots Alliance news, Chairman Stefano Pessina purchased 832,258 shares of Walgreens Boots Alliance stock in a transaction dated Sunday, April 27th. The shares were acquired at an average price of $11.01 per share, with a total value of $9,163,160.58. Following the completion of the transaction, the chairman now owns 145,621,079 shares of the company's stock, valued at $1,603,288,079.79. This trade represents a 0.57% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 17.50% of the company's stock.

Analysts Set New Price Targets

Several research analysts recently commented on WBA shares. Deutsche Bank Aktiengesellschaft downgraded Walgreens Boots Alliance from a "hold" rating to a "sell" rating and reduced their price objective for the company from $11.00 to $9.00 in a research note on Friday, February 28th. Wall Street Zen started coverage on shares of Walgreens Boots Alliance in a research report on Wednesday, May 21st. They set a "hold" rating on the stock. Truist Financial dropped their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a research note on Friday, January 31st. Finally, Wolfe Research raised shares of Walgreens Boots Alliance to a "hold" rating in a research note on Monday, February 24th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, Walgreens Boots Alliance has an average rating of "Hold" and a consensus price target of $10.59.

Walgreens Boots Alliance Trading Up 0.0%

Shares of NASDAQ:WBA traded up $0.01 during midday trading on Tuesday, reaching $11.18. 2,797,129 shares of the company's stock were exchanged, compared to its average volume of 20,884,601. The firm's 50 day simple moving average is $11.02 and its two-hundred day simple moving average is $10.44. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $16.34. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The stock has a market cap of $9.66 billion, a price-to-earnings ratio of -1.09, a P/E/G ratio of 1.31 and a beta of 0.77.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, topping the consensus estimate of $0.53 by $0.10. The firm had revenue of $38.59 billion for the quarter, compared to analyst estimates of $37.90 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business's revenue for the quarter was up 4.1% compared to the same quarter last year. During the same period in the prior year, the business posted $1.20 EPS. As a group, sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.